The order of administration of trastuzumab to SN-38 infl uences SN-38's cytotoxicity in gastric cancer cell lines with or without HER2 expression

被引:0
|
作者
Yamade, M. [1 ]
Sugimoto, M. [1 ]
Nishino, M. [1 ]
Uotani, T. [1 ]
Sahara, S. [1 ]
Furuta, T. [2 ]
机构
[1] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka, Japan
[2] Hamamatsu Univ Sch Med, Clin Res Ctr, Hamamatsu, Shizuoka, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:46 / 47
页数:2
相关论文
共 50 条
  • [31] Analysis of Type of Cell Death Induced by Topoisomerase Inhibitor SN-38 in Human Oral Squamous Cell Carcinoma Cell Lines
    Tamura, Nozomi
    Hirano, Kumi
    Kishino, Kaori
    Hashimoto, Ken
    Amano, Osamu
    Shimada, Jun
    Sakagami, Hiroshi
    ANTICANCER RESEARCH, 2012, 32 (11) : 4823 - 4832
  • [32] The effect of SN-38 on cell proliferation and on production of urokinase-type plasminogen activator and its inhibitor in human lung cancer cell lines
    Ishikawa, H
    Satoh, H
    Kamma, H
    Naito, T
    Ohtsuka, M
    Ogata, T
    Hasegawa, S
    CANCER RESEARCH THERAPY & CONTROL, 1998, 5 (02): : 97 - 105
  • [33] NK012 (A NANODEVICE FORMULATION OF SN-38) IN PATIENTS WITH RELAPSED SMALL-CELL LUNG CANCER
    Spigel, David R.
    Hainsworth, John
    Infante, Jeffrey R.
    Bendell, Johanna
    Jones, Suzanne
    Lipman, Andy
    Trent, David
    Raefsky, Eric
    Greco, F. A.
    Burris, Howard
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S644 - S644
  • [34] β-Casein micelles for oral delivery of SN-38 and elacridar to overcome BCRP-mediated multidrug resistance in gastric cancer
    Bar-Zeev, Maya
    Kelmansky, Daniel
    Assaraf, Yehuda G.
    Livney, Yoav D.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2018, 133 : 240 - 249
  • [35] Paclitaxel and SN-38 overcome cisplatin resistance of ovarian cancer cell lines by down-regulating the influx and efflux system of cisplatin
    Komuro, Y
    Udagawa, Y
    Susumu, N
    Aoki, D
    Kubota, T
    Nozawa, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (11): : 1242 - 1250
  • [36] Mechanistic biosynthesis of SN-38 coated reduced graphene oxide sheets for photothermal treatment and care of patients with gastric cancer
    Chen, Jing
    He, Guang-Mei
    Xian, Guang-Yan
    Su, Xiao-Qing
    Yu, Lei-Lei
    Yao, Feng
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2020, 204
  • [37] Preparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT-29 cell lines
    Ebrahimnejad, Pedram
    Dinarvand, Rassoul
    Sajadi, Abolghasem
    Jaafari, Mahmoud Reza
    Nomani, Ali Reza
    Azizi, Ebrahim
    Rad-Malekshahi, Mazda
    Atyabi, Fatemeh
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2010, 6 (03) : 478 - 485
  • [38] Combined efficacy of trifluridine and SN-38 in a 5-FU-resistant human colorectal cancer cell line
    Matsuoka, Kazuaki
    Kobunai, Takashi
    Takechi, Teiji
    CANCER RESEARCH, 2016, 76
  • [39] Marked of cytotoxicity of SN-38 and novel camptothecin derivatives to chronic B-cell lymphocytic leukemia lymphocytes in vitro.
    Cohen, DP
    Adams, DJ
    Colvin, OK
    Wall, ME
    Wani, MC
    Flowers, JL
    Fanning, JE
    Silber, R
    BLOOD, 1997, 90 (10) : 2371 - 2371
  • [40] Role of ABCG2 as a biomarker for predicting resistance to CPT-11/SN-38 in lung cancer
    Bessho, Y
    Oguri, T
    Achiwa, H
    Muramatsu, H
    Maeda, H
    Niimi, T
    Sato, S
    Ueda, R
    CANCER SCIENCE, 2006, 97 (03) : 192 - 198